Search Results - "Coindre, J. M."

Validation of the Complexity INdex in SARComas prognostic signature on formalin-fixed, paraffin-embedded, soft-tissue sarcomas by Le Guellec, S., Lesluyes, T., Sarot, E., Valle, C., Filleron, T., Rochaix, P., Valentin, T., Pérot, G., Coindre, J.-M., Chibon, F.

“…Prediction of metastatic outcome in sarcomas is challenging for clinical management since they are aggressive and carry a high metastatic risk. A 67-gene…”
Get full text

Improved survival using specialized multidisciplinary board in sarcoma patients by Blay, J.-Y., Soibinet, P., Penel, N., Bompas, E., Duffaud, F., Stoeckle, E., Mir, O., Adam, J., Chevreau, C., Bonvalot, S., Rios, M., Kerbrat, P., Cupissol, D., Anract, P., Gouin, F., Kurtz, J. -E., Lebbe, C., Isambert, N., Bertucci, F., Toumonde, M., Thyss, A., Piperno-Neumann, S., Dubray-Longeras, P., Meeus, P., Ducimetière, F., Giraud, A., Coindre, J. -M., Ray-Coquard, I., Italiano, A., Le Cesne, A.

“…Sarcomas are rare but aggressive diseases. Specialized multidisciplinary management is not implemented for all patients in most countries. We investigated the…”
Get full text

Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab by Cousin, S., Toulmonde, M., Kind, M., Cazeau, A.-L., Bechade, D., Coindre, J.-M., Italiano, A.

Get full text

Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival by Italiano, A., Toulmonde, M., Cioffi, A., Penel, N., Isambert, N., Bompas, E., Duffaud, F., Patrikidou, A., Lortal, B., Le Cesne, A., Blay, J.-Y., Maki, R.G., Schwartz, G.K., Antonescu, C.R., Singer, S., Coindre, J.-M., Bui, B.

“…Data regarding the role of systemic therapy in patients with advanced well-differentiated/dedifferentiated liposarcomas (WDLPS/DDLPS) are limited. From 2000 to…”
Get full text

Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG) by Garbay, D., Le Cesne, A., Penel, N., Chevreau, C., Marec-Berard, P., Blay, J.-Y., Debled, M., Isambert, N., Thyss, A., Bompas, E., Collard, O., Salas, S., Coindre, J.-M., Bui, B., Italiano, A.

“…Data regarding the role of chemotherapy (CT) in patients with recurrent and/or unresectable desmoid tumors (DTs) are scarce. Records of patients with DT who…”
Get full text

Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database by Italiano, A., Delva, F., Mathoulin-Pelissier, S., Le Cesne, A., Bonvalot, S., Terrier, P., Trassard, M., Michels, J.-J., Blay, J.-Y., Coindre, J.-M., Bui, B.

“…The predictive value of grade for benefit from adjuvant chemotherapy (AC) in soft tissue sarcoma (STS) patients has never been explored. From 1980 to 1999,…”
Get full text

GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study by Italiano, A., Le Cesne, A., Bellera, C., Piperno-Neumann, S., Duffaud, F., Penel, N., Cassier, P., Domont, J., Takebe, N., Kind, M., Coindre, J.-M., Blay, J.-Y., Bui, B.

“…Pre-clinical data have suggested a therapeutic role of Hedgehog (Hh) pathway inhibitors in chondrosarcoma. This phase II trial included patients with…”
Get full text

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group by Italiano, A., Penel, N., Robin, Y.-M., Bui, B., Le Cesne, A., Piperno-Neumann, S., Tubiana-Hulin, M., Bompas, E., Chevreau, C., Isambert, N., Leyvraz, S., du Chatelard, P. P., Thyss, A., Coindre, J.-M., Blay, J.-Y.

“…Background: There are only scarce data about the benefit of adjunctive chemotherapy in patients with localized synovial sarcoma (SS). Patients and methods:…”
Get full text

Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study by Cassier, P.A., Kantor, G., Bonvalot, S., Lavergne, E., Stoeckle, E., Le Péchoux, C., Meeus, P., Sunyach, M.-P., Vaz, G., Coindre, J.-M., Linassier, C., Labib, A., Delcambre, C., Bay, J.-O., Leyvraz, S., Dubergé, T., Lagrange, J.-L., Duret, A., Blay, J.-Y.

“…The role of adjuvant radiotherapy (RT) in the management of atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WD-LPS) remains controversial. Two…”
Get full text

Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions by Ray-Coquard, I., Montesco, M.C., Coindre, J.M., Dei Tos, A.P., Lurkin, A., Ranchère-Vince, D., Vecchiato, A., Decouvelaere, A.V., Mathoulin-Pélissier, S., Albert, S., Cousin, P., Cellier, D., Toffolatti, L., Rossi, C.R., Blay, J.Y.

“…Sarcomas represent a heterogeneous group of tumors. Accurate determination of histological diagnosis and prognostic factors is critical for the delineation of…”
Get full text

Treatment with the mTOR inhibitor temsirolimus in patients with malignant PEComa by Italiano, A., Delcambre, C., Hostein, I., Cazeau, A.L., Marty, M., Avril, A., Coindre, J.-M., Bui, B.

Get full text

Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases by Fayette, J., Martin, E., Piperno-Neumann, S., Le Cesne, A., Robert, C., Bonvalot, S., Ranchère, D., Pouillart, P., Coindre, J.M., Blay, J.Y.

“…Angiosarcomas are rare, heterogeneous and a retrospective study was conducted to describe their natural history. We reviewed 161 files of angiosarcoma treated…”
Get full text

Clinical outcome of leiomyosarcomas of vascular origin: comparison with leiomyosarcomas of other origin by Italiano, A., Toulmonde, M., Stoeckle, E., Kind, M., Kantor, G., Coindre, J.-M., Bui, B.

“…There are no data about the natural history of leiomyosarcoma of vascular origin (vLMS) in comparison with leiomyosarcoma (LMS) of other origin and about the…”
Get full text

Specific immune landscapes and immune checkpoint expressions in histotypes and molecular subtypes of sarcoma by Dufresne, A., Lesluyes, T., Ménétrier-Caux, C., Brahmi, M., Darbo, E., Toulmonde, M., Italiano, A., Mir, O., Le Cesne, A., Le Guellec, S., Valentin, T., Chevreau, C., Bonvalot, S., Robin, Y.M., Coindre, J-M, Caux, C., Blay, J.Y., Chibon, F.

“…Soft tissue sarcomas are a group of rare and aggressive connective tissue neoplasms for which curative therapeutic opportunities are limited in advanced phase…”
Get full text

Intra-articular nodular fasciitis of the proximal interphalangeal joint of a finger: A case report by Choughri, H., Coindre, J.-M., Leclère, F.M.

“…Nodular fasciitis is a benign reactive lesion, often mistaken for a soft-tissue sarcoma in clinical practice. Involvement of the finger is rare, and a finger…”
Get full text

Soft tissue masses with myxoid stroma: can conventional magnetic resonance imaging differentiate benign from malignant tumors? by Crombe, A, Alberti, N, Stoeckle, E, Brouste, V, Buy, X, Coindre, J-M, Kind, M

“…Abstract Objectives To retrospectively evaluate the diagnostic performance of morphological signs observed on conventional magnetic resonance (MR) imaging to…”
Get full text

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management by Dômont, J, Salas, S, Lacroix, L, Brouste, V, Saulnier, P, Terrier, P, Ranchère, D, Neuville, A, Leroux, A, Guillou, L, Sciot, R, Collin, F, Dufresne, A, Blay, J-Y, Le Cesne, A, Coindre, J-M, Bonvalot, S, Bénard, J

“…Background: Fibromatosis comprises distinct clinical entities, including sporadic extra-abdominal fibromatosis, which have a high tendency for recurrence, even…”
Get full text

Meningeal SWI/SNF related, matrix‐associated, actin‐dependent regulator of chromatin, subfamily B member 1 (SMARCB1)‐deficient tumours: an emerging group of meningeal tumours by Dadone, B., Fontaine, D., Mondot, L., Cristofari, G., Jouvet, A., Godfraind, C., Varlet, P., Ranchère‐Vince, D., Coindre, J.‐M., Gastaud, L., Baudoin, C., Peyron, A.‐C., Thyss, A., Coutts, M., Michiels, J.‐F., Pedeutour, F., Burel‐Vandenbos, F.

“…Aims Bi‐allelic inactivation of SWI/SNF related, matrix‐associated, actin‐dependent regulator of chromatin, subfamily B member 1 (SMARCB1; also known as INI1)…”
Get full text

Adherence to consensus-based diagnosis and treatment guidelines in adult soft-tissue sarcoma patients: a French prospective population-based study by Mathoulin-Pélissier, S., Chevreau, C., Bellera, C., Bauvin, E., Savès, M., Grosclaude, P., Albert, S., Goddard, J., Le Guellec, S., Delannes, M., Bui, B.N., Mendiboure, J., Stoeckle, E., Coindre, J.M., Kantor, G., Kind, M., Cowppli-Bony, A., Hoppe, S., Italiano, A.

“…Soft-tissue sarcomas (STSs) are rare tumors with varied histological presentations. Management and treatment are thus complex, but crucial for patient…”
Get full text

Immunohistochemistry in the diagnosis of soft tissue tumours by Coindre, J M

“…Immunohistochemistry is particularly important in the field of soft tissue tumours because of their variety and the frequent difficulty of diagnosis. The first…”
Get full text